COMPANY
Pluristyx
Funding and NIH signals
- SEC Form D raise Raised $9.76M (Form D filed Jul 13, 2026). SEC Form D 0001991664-26-000003 (Jul 13, 2026)
Evidence (1 event)
- Jul 13, 2026 · SEC Form D 0001991664-26-000003
Name of Issuer: Pluristyx Inc.; CIK: 1991664; Address: Seattle, WA; Submission type: D; Filing date: 2026-07-13; Industry Group: Biotechnology; Date of First Sale: 2026-07-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 14757793; Total Amount Sold: 9757789; Federal exemptions: 06b
- Jul 13, 2026 · SEC Form D 0001991664-26-000003
Raises and deals from press releases
- Raise Series A · amount not disclosed · announced Jul 6, 2026 Company release ↗
Source quote
- Jul 6, 2026 · Company release ↗
“SEATTLE, WA – July 6, 2026 – Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with participation from existing investors”
- Jul 6, 2026 · Company release ↗